KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Kim, Javed Khan, Berkley E. Gryder et al.|Nature Communications|2024Cited by 19
Chemical Evolution of Aplithianine Class of Serine/Threonine Kinase InhibitorsLin Du, Barry R. O’Keefe, Shilpa R. Shenoy et al.|Journal of Medicinal Chemistry|2025Cited by 2